Being confirmed that NDRG1, p-NDRG1 (Thr346) expression, and subcellular localization is associated with poorer survival of TNBC patients and that it is involved in tumor progression induced by TGFβ signaling, our final goal was to propose a potential way for their personalized treatment. This evidence concerns the gene NDRG1 and neoplasm.